Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 41.92%
March 31, 2026 39.23%
December 31, 2025 40.28%
September 30, 2025 36.87%
June 30, 2025 39.28%
March 31, 2025 37.45%
December 31, 2024 37.79%
September 30, 2024 41.80%
June 30, 2024 38.21%
March 31, 2024 41.57%
December 31, 2023 42.11%
September 30, 2023 42.93%
June 30, 2023 43.28%
March 31, 2023 42.37%
December 31, 2022 36.81%
September 30, 2022 43.68%
June 30, 2022 41.54%
March 31, 2022 43.12%
December 31, 2021 38.71%
September 30, 2021 39.60%
June 30, 2021 32.86%
March 31, 2021 31.15%
December 31, 2020 28.52%
September 30, 2020 39.27%
June 30, 2020 37.70%
Date Value
March 31, 2020 34.74%
December 31, 2019 38.49%
September 30, 2019 36.59%
June 30, 2019 34.33%
March 31, 2019 32.85%
December 31, 2018 33.68%
September 30, 2018 38.11%
June 30, 2018 35.73%
March 31, 2018 36.83%
December 31, 2017 40.15%
September 30, 2017 40.10%
June 30, 2017 41.97%
March 31, 2017 39.90%
December 31, 2016 41.04%
September 30, 2016 42.18%
June 30, 2016 46.03%
March 31, 2016 43.20%
December 31, 2015 44.94%
September 30, 2015 50.06%
June 30, 2015 44.15%
March 31, 2015 45.77%
December 31, 2014 49.86%
September 30, 2014 50.22%
June 30, 2014 44.32%
March 31, 2014 52.60%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Pfizer Inc. 62.94%
Eli Lilly & Co. 85.78%
Merck & Co., Inc. 71.51%
Bristol Myers Squibb Co. 67.95%
Johnson & Johnson 68.73%

Gross Profit Margin (Quarterly) Related Metrics